Expert opinion on emerging drugs.

ISSN 1472-8214Taylor and Francis Ltd.United Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Titles
Expert Opinion on Emerging Drugs
Expert Opin. Emerg. Drugs (abbreviated)
EXPERT OPINION ON EMERGING DRUGS TAYLOR & FRANCIS LTD
Expert opinion on emerging drugs.
Expert Opin Emerg Drugs (abbreviated)
ISSN
1472-8214
1472-8214
eISSN
1744-7623
NLM ID
101135662
Publisher
Taylor and Francis Ltd.
London, UK : Ashley Publications Ltd.
Country
Language
ENG
English

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2000–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20252.7Q25704JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.908
Best Quartile
Q2
H-index
59
Subject categories
  • Pharmacology — Q2
  • Pharmacology (medical) — Q2
More metrics
Coverage
2000–2025
Country
United Kingdom
Region
Western Europe
Publisher
Taylor and Francis Ltd.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
22
Total documents (3 years)
96
Total references
1674
Total citations (3 years)
308
Citable documents (3 years)
83
Citations per document (2 years)
3.44
References per document
76.09
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1472-8214, 1744-7623
SCImago Source ID
21350
SCImago Rank (across all SCImago source types)
5701

Publication activity

Publication activity
2025
22 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Drug Design; Drug Industry; Pharmaceutical Preparations; Research
Scopus:2000-2026
MEDLINE:MEDLINE: v8n1, May 2003-; Index medicusIn: PubMed: v8n1, May 2003-;
PubMed:MEDLINE: v8n1, May 2003-; Index medicusIn: PubMed: v8n1, May 2003-;